Cargando…

Myeloid-Derived Suppressor Cells in COVID-19: The Paradox of Good

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of the ongoing coronavirus disease 2019 (COVID-19) pandemic. Viral replication in the respiratory tract induces the death of infected cells and the release of pathogen- associated molecular patterns (PAMPs). PAMPs gi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Grassi, Germana, Notari, Stefania, Gili, Simona, Bordoni, Veronica, Casetti, Rita, Cimini, Eleonora, Tartaglia, Eleonora, Mariotti, Davide, Agrati, Chiara, Sacchi, Alessandra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9092297/ https://www.ncbi.nlm.nih.gov/pubmed/35572540 http://dx.doi.org/10.3389/fimmu.2022.842949

Ejemplares similares

Expansion of Myeloid Derived Suppressor Cells Contributes to Platelet Activation by L-Arginine Deprivation during SARS-CoV-2 Infection
por: Sacchi, Alessandra, et al.
Publicado: (2021)

Myeloid-Derived Suppressor Cells Specifically Suppress IFN-γ Production and Antitumor Cytotoxic Activity of Vδ2 T Cells
por: Sacchi, Alessandra, et al.
Publicado: (2018)

A new procedure to analyze polymorphonuclear myeloid derived suppressor cells in cryopreserved samples cells by flow cytometry
por: Sacchi, Alessandra, et al.
Publicado: (2018)

The interplay between SARS-CoV-2 infected airway epithelium and immune cells modulates regulatory/inflammatory signals
por: Bordoni, Veronica, et al.
Publicado: (2022)

Early expansion of myeloid-derived suppressor cells inhibits SARS-CoV-2 specific T-cell response and may predict fatal COVID-19 outcome
por: Sacchi, Alessandra, et al.
Publicado: (2020)

Myeloid Derived Suppressor Cells Expansion Persists After Early ART and May Affect CD4 T Cell Recovery
por: Agrati, Chiara, et al.
Publicado: (2019)

Expansion of myeloid-derived suppressor cells in patients with severe coronavirus disease (COVID-19)
por: Agrati, Chiara, et al.
Publicado: (2020)

The unbalanced p53/SIRT1 axis may impact lymphocyte homeostasis in COVID-19 patients
por: Bordoni, Veronica, et al.
Publicado: (2021)

PMN-MDSC Frequency Discriminates Active Versus Latent Tuberculosis and Could Play a Role in Counteracting the Immune-Mediated Lung Damage in Active Disease
por: Grassi, Germana, et al.
Publicado: (2021)

HIV Infection of Monocytes-Derived Dendritic Cells Inhibits Vγ9Vδ2 T Cells Functions
por: Sacchi, Alessandra, et al.
Publicado: (2014)

An Inflammatory Profile Correlates With Decreased Frequency of Cytotoxic Cells in Coronavirus Disease 2019
por: Bordoni, Veronica, et al.
Publicado: (2020)

Per2 Upregulation in Circulating Hematopoietic Progenitor Cells During Chronic HIV Infection
por: Bordoni, Veronica, et al.
Publicado: (2020)

Vδ2 T-Cells Kill ZIKV-Infected Cells by NKG2D-Mediated Cytotoxicity
por: Cimini, Eleonora, et al.
Publicado: (2019)

In Acute Dengue Infection, High TIM-3 Expression May Contribute to the Impairment of IFNγ Production by Circulating Vδ2 T Cells
por: Cimini, Eleonora, et al.
Publicado: (2022)

In Vitro and In Vivo Crosstalk between Type I IFN and IL-8 Responses in SARS-CoV-2 Infection
por: Biava, Mirella, et al.
Publicado: (2023)

Vγ9Vδ2 T-Cell Polyfunctionality Is Differently Modulated in HAART-Treated HIV Patients according to CD4 T-Cell Count
por: Casetti, Rita, et al.
Publicado: (2015)

Primary and Chronic HIV Infection Differently Modulates Mucosal Vδ1 and Vδ2 T-Cells Differentiation Profile and Effector Functions
por: Cimini, Eleonora, et al.
Publicado: (2015)

SARS-CoV-2 Infection of Airway Epithelium Triggers Pulmonary Endothelial Cell Activation and Senescence Associated with Type I IFN Production
por: Bordoni, Veronica, et al.
Publicado: (2022)

Human Zika infection induces a reduction of IFN-γ producing CD4 T-cells and a parallel expansion of effector Vδ2 T-cells
por: Cimini, Eleonora, et al.
Publicado: (2017)

Use of Pembrolizumab for Treatment of Progressive Multifocal Leukoencephalopathy in People Living with HIV
por: Pinnetti, Carmela, et al.
Publicado: (2022)

γδ T Cells in Emerging Viral Infection: An Overview
por: Cimini, Eleonora, et al.
Publicado: (2022)

T helper profile in pregnant women recovered from COVID-19
por: Tartaglia, Eleonora, et al.
Publicado: (2022)

SARS-CoV-2 Specific Immune Response and Inflammatory Profile in Advanced HIV-Infected Persons during a COVID-19 Outbreak
por: Vergori, Alessandra, et al.
Publicado: (2022)

Safety and immune response kinetics of GRAd-COV2 vaccine: phase 1 clinical trial results
por: Agrati, Chiara, et al.
Publicado: (2022)

Interferon-α Improves Phosphoantigen-Induced Vγ9Vδ2 T-Cells Interferon-γ Production during Chronic HCV Infection
por: Cimini, Eleonora, et al.
Publicado: (2012)

Immunological signature in human cases of monkeypox infection in 2022 outbreak: an observational study
por: Agrati, Chiara, et al.
Publicado: (2023)

Impact of Prior Influenza and Pneumoccocal Vaccines on Humoral and Cellular Response to SARS-CoV-2 BNT162b2 Vaccination
por: Puro, Vincenzo, et al.
Publicado: (2021)

Coordinate Induction of Humoral and Spike Specific T-Cell Response in a Cohort of Italian Health Care Workers Receiving BNT162b2 mRNA Vaccine
por: Agrati, Chiara, et al.
Publicado: (2021)

Strong immunogenicity of heterologous prime-boost immunizations with the experimental vaccine GRAd-COV2 and BNT162b2 or ChAdOx1-nCOV19
por: Agrati, Chiara, et al.
Publicado: (2021)

The Role of P-Selectin in COVID-19 Coagulopathy: An Updated Review
por: Agrati, Chiara, et al.
Publicado: (2021)

Paradoxes in the Phenotype, Frequency and Roles of Myeloid-Derived Suppressor Cells During HIV Infection
por: Ademe, Muluneh
Publicado: (2020)

Persistent Spike-specific T cell immunity despite antibody reduction after 3 months from SARS-CoV-2 BNT162b2-mRNA vaccine
por: Agrati, Chiara, et al.
Publicado: (2022)

Neutralizing activity and T Cell response after bivalent fifth dose of mRNA vaccine in person living with HIV
por: Vergori, Alessandra, et al.
Publicado: (2023)

Paradoxical myeloid-derived suppressor cell reduction in the bone marrow of SIV chronically infected macaques
por: Sui, Yongjun, et al.
Publicado: (2017)

The immune response as a double‐edged sword: The lesson learnt during the COVID‐19 pandemic
por: Agrati, Chiara, et al.
Publicado: (2022)

Mechanisms Underlying the Role of Myeloid-Derived Suppressor Cells in Clinical Diseases: Good or Bad
por: Ge, Yongtong, et al.
Publicado: (2021)

Peripheral myeloid-derived suppressor cells are good biomarkers of the efficacy of fingolimod in multiple sclerosis
por: Camacho-Toledano, Celia, et al.
Publicado: (2022)

Immunogenicity to COVID-19 mRNA vaccine third dose in people living with HIV
por: Vergori, Alessandra, et al.
Publicado: (2022)

Janus-Faced Myeloid-Derived Suppressor Cell Exosomes for the Good and the Bad in Cancer and Autoimmune Disease
por: Zöller, Margot
Publicado: (2018)

Humoral and Cellular Immune Response Elicited by mRNA Vaccination Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in People Living With Human Immunodeficiency Virus Receiving Antiretroviral Therapy Based on Current CD4 T-Lymphocyte Count
por: Antinori, Andrea, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gomnp94nmpevfm4rk4m25brvqc